Citius Oncology, Inc.
CTORNASDAQHealthcare● Active
$0.80
+$0.02(+2.55%)
Market Cap$74375662
P/E Ratio—
52W High$6.19
52W Low$0.491
Citius Oncology, Inc. (CTOR) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CTOR · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-09 | 2024-09 | 2023-09 | 2022-09 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — | — | — |
| Operating Expenses | ||||
| R&D Expenses | $0.01B | $0.00B | $0.00B | $0.01B |
| G&A Expenses | $0.02B | $0.02B | $0.01B | $0.00B |
| Total Operating Expenses | $0.02B | $0.02B | $0.01B | $0.01B |
| Operating Income | ($0.02B) | ($0.02B) | ($0.01B) | ($0.01B) |
| Operating Margin %(computed) | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.02B) | ($0.02B) | ($0.01B) | ($0.01B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.02B) | ($0.02B) | ($0.01B) | ($0.01B) |
| Net Margin %(computed) | — | — | — | — |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-0.34 | $-0.30 | $-0.19 | $-0.08 |
| Wtd Avg Shares | 0.07B | 0.07B | 0.09B | 0.09B |
| EBITDA | ($0.02B) | ($0.02B) | ($0.01B) | $0.00B |
| EBITDA Margin %(computed) | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Citius Oncology, Inc. data
About Citius Oncology, Inc. (CTOR) Income Statement
Citius Oncology, Inc. (CTOR) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CTOR reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of ($0.02B) — a net profit margin of —.
Frequently asked questions
CTOR · 4 questionsCitius Oncology, Inc. (CTOR) reported revenue of $0.00B for 2025, down —% year-over-year.
CTOR revenueCTOR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09